HEMA - HemaCare Corporation

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue13,8769,70216,245
Cost of Revenue6,7515,29213,887
Gross Profit7,1254,4102,358
Operating Expenses
Research Development---
Selling General and Administrative6,3265,7904,707
Non Recurring---
Total Operating Expenses---
Operating Income or Loss799-1,380-2,349
Income from Continuing Operations
Total Other Income/Expenses Net--192
Earnings Before Interest and Taxes799-1,380-2,157
Interest Expense---
Income Before Tax799-1,380-2,157
Income Tax Expense182210
Minority Interest---
Net Income From Continuing Ops781-1,402-2,167
Non-recurring Events
Discontinued Operations-4,6381,362
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income7813,236-805
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares7813,236-805